Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,825 | -12,132 | -26,992 | -29,122 | -23,470 |
| Depreciation Amortization | 809 | 754 | 1,667 | 1,927 | 1,819 |
| Accounts receivable | 1,754 | -1,599 | -850 | -1,085 | 140 |
| Accounts payable and accrued liabilities | -402 | -1,231 | 752 | 77 | -818 |
| Other Working Capital | 1,123 | -1,953 | 530 | -3,577 | -2,164 |
| Other Operating Activity | 3,786 | 389 | 2,728 | 554 | -504 |
| Operating Cash Flow | $-8,755 | $-15,772 | $-22,165 | $-31,226 | $-24,997 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -60 | -131 | -456 | -1,096 |
| Investing Cash Flow | $N/A | $-60 | $-131 | $-456 | $-1,096 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,078 | 0 | N/A | N/A | 6,930 |
| Debt Repayment | -2,790 | -2,377 | -2,174 | -54 | -79 |
| Common Stock Issued | 10,416 | 21,416 | 4,447 | 42,622 | 16,629 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -173 |
| Financing Cash Flow | $10,704 | $19,039 | $2,273 | $42,568 | $23,307 |
| Exchange Rate Effect | 41 | 10 | -135 | 81 | 80 |
| Beginning Cash Position | 10,872 | 7,655 | 27,813 | 16,846 | 19,552 |
| End Cash Position | 12,862 | 10,872 | 7,655 | 27,813 | 16,846 |
| Net Cash Flow | $1,990 | $3,217 | $-20,158 | $10,967 | $-2,706 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,755 | -15,772 | -22,165 | -31,226 | -24,997 |
| Capital Expenditure | N/A | -60 | -131 | -456 | -1,096 |
| Free Cash Flow | -8,755 | -15,832 | -22,296 | -31,682 | -26,093 |